Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis-Reference-Cited by-同舟云学术

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis

Published:2015-09-17 Issue:9 Volume:10 Page:e0138264
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kerbert Annarein J. C.,Verbeke Len,Chiang Fang W. T.,Laleman Wim,van der Reijden Johan J.,van Duijn Wim,Nevens Frederik,Wolterbeek Ron,van Hoek Bart,Verspaget Hein W.,Coenraad Minneke J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis;RW Schrier;Hepatology,1988

2. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis;J Bosch;Gastroenterology,1980

3. Renal failure in cirrhosis;P Gines;N Engl J Med,2009

4. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis;F Salerno;Gut,2007

5. Model for end-stage liver disease (MELD) and allocation of donor livers;R Wiesner;Gastroenterology,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis;Gut;2023-10-26

2. Circulating copeptin level and the clinical prognosis of patients with chronic liver disease;World Journal of Gastroenterology;2023-08-21

3. Copeptin in fluid disorders and stress;Clinica Chimica Acta;2022-04

4. Response from Piotr Mieszcazanski regarding Ceren Gunt's letter-RE: “Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study”;Transplantation Proceedings;2021-12

5. RE: Piotr Mieszczanski et al: “Copeptin (CTproAVP)—A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study”;Transplantation Proceedings;2021-12